About 2 Mg Bortezest Injection
Discover top-tier efficacy with 2 Mg Bortezest Injection by Zest Pharma, a premier chemotherapeutic agent meeting IP/BP standards. Engineered for instant checkout and elite patient care, this lyophilized powder reconstitutes effortlessly with 0.9% sodium chloride. Enjoy significant savings for distributors, suppliers, and traders throughout India. Packed in a secure vial, it promises top-notch stability for up to 24 months. Bortezest is indicated for multiple myeloma and mantle cell lymphoma, available by prescription only, ensuring exclusive, professional use for optimal therapeutic outcomes.
Commercial Uses and Key Features of 2 Mg Bortezest Injection
2 Mg Bortezest Injection is widely utilized in oncology settings for the premier treatment of multiple myeloma and mantle cell lymphoma. This elite product features a clear, colorless to pale yellow lyophilized powder, ready for reconstitution with normal saline. Used as an intravenous or subcutaneous injection, Bortezest offers reliable performance for hospitals and clinics, ensuring patients receive top-notch care and therapeutic efficacy in controlling advanced malignancies.
Certifications, Logistics, and Distribution for Bortezest Injection
The 2 Mg Bortezest Injection boasts IP/BP certifications, ensuring it adheres to international pharmacopoeia standards. Shipped from prominent FOB ports across India, the logistics chain guarantees prompt delivery and secure handling for every batch. The product is distributed primarily throughout the main domestic market in India, with streamlined exchange and robust network support to facilitate smooth supply to pharmacies, healthcare facilities, and authorized medical distributors.
FAQ's of 2 Mg Bortezest Injection:
Q: How should 2 Mg Bortezest Injection be administered?
A: 2 Mg Bortezest Injection is administered either intravenously or subcutaneously after reconstitution with 0.9% sodium chloride (normal saline) by a qualified healthcare professional.
Q: What conditions is Bortezest Injection primarily used to treat?
A: This injection is indicated for the treatment of multiple myeloma and mantle cell lymphoma, providing advanced care options for these cancers.
Q: When should the reconstituted solution of Bortezest be used?
A: After reconstitution, the solution should be used within 8 hours if stored at 25C, ensuring its effectiveness and safety during therapy.
Q: Where is Bortezest Injection manufactured and distributed?
A: Bortezest Injection is manufactured and authorized by Zest Pharma in India and is distributed across the main domestic Indian market.
Q: What are the key storage instructions for this product?
A: Store the unopened vial in a dry, cool place. Once reconstituted, keep the solution at 25C and use within 8 hours to maintain quality.
Q: What benefits does the lyophilized powder form provide?
A: The lyophilized powder form enhances stability and shelf life, allowing for convenient storage, easy transport, and precise reconstitution before administration.